Patients testing positive for NPM1 MRD pre-alloHCT have significantly increased rates of relapse, reduced overall survival ...

ASH convened a multidisciplinary panel to develop evidence-based guidelines for the treatment of newly diagnosed acute myeloid leukemia in older adults, focusing on balancing treatment efficacy with ...

HLF-positive B cell acute lymphoblastic leukemia (B-ALL) sits among the most aggressive blood cancers seen in children. The ...

Yatiri Bio, Inc., a leader in AI-driven precision medicine, today announced it has entered into an exclusive global option to ...

AML induction shifts beyond 7+3 as venetoclax, hypomethylating agents, and FLT3 inhibitors drive less toxic combos and oral ...

HLF-positive B cell acute lymphoblastic leukemia (B-ALL) sits among the most aggressive blood cancers seen in ...

Myeloma delivery constraints are dominated by CAR T infrastructure and onboarding, while bispecifics are more ...

Oncotelic Therapeutics, Inc. (OTCQB:OTLC) ("Oncotelic", the "Company" or "We" or “Our”), a leader in RNA-based therapeutics, announced today that its subsidiary Sapu Nano will formally introduce its ...

The making of Edgerrin James: Gold teeth, Colts Big Man, Grandma Annie and moving like a turtle -- slow and efficient.

DKMS recognizes outstanding research and supports young scientists in the field of stem cell transplantation and cell therapy for hematological diseases at the conference of the European Society For ...

Yatiri used its AI-based proteomics and functional testing platform to identify a biomarker profile for best responders to denfivontinib.

Mumbai: Narayana Health SRCC Children’s Hospital, Mumbai, has successfully treated 12-year-old Pradeep Kumar (patient), who was battling a rare and aggressive progressive leukemia. The ...